-
Translation: PTC Therapeutics
@PTCbio announced at the 38th annual J.P. Morgan Healthcare 2020 conference, the continuation of PTC-FA gene therapy for#Friedreich#ataxia which should lead to clinical trials in the 3rd quarter of 2020https://twitter.com/Asso_Alatax/status/1223009898046414848 …
-
PTC Therapeutics @PTCbio a annoncé lors de la 38ème conférence annuelle J.P. Morgan Healthcare 2020 la poursuite de la thérapie génique PTC-FA pour l'#ataxie de#Friedreich qui devrait déboucher sur des essais cliniques au 3ème trimestre 2020 https://www.alatax.fr/la-recherche/annonces/friedreich-ataxia-scientific-news …#ataxia pic.twitter.com/ILXFbwFUN7
-
#mdpidiagnostics#Ocular Involvement in#Friedreich#Ataxia Patients and its Relationship with#Neurological Disability, a Follow-up Study@iacs_aragon
https://www.mdpi.com/2075-4418/10/2/75 …pic.twitter.com/PKliQ9zqY7
-
In the JANUARY ISSUE: Predictors of loss of ambulation in
#Friedreich's#ataxia#openaccess https://bit.ly/2t6paWf pic.twitter.com/Olkl7y8mA6
-
.
@MDAorg a annoncé l'attribution d'une subvention de 1 million $ pour faire avancer l'essai clinique de phase 2 d'#AavantiBio sur une thérapie de remplacement génétique pour l'#ataxie de#Friedreich https://www.alatax.fr/la-recherche/annonces/friedreich-ataxia-scientific-news …#ataxia#RareDisease@JuanCBaiges pic.twitter.com/NPUfs8ldwk
-
Our paper on longitudinal change in brain activation in Friedreich ataxia is now at https://rdcu.be/b0vLU We investigated changes in fMRI, associated with working memory performance, and grey matter volume over 24 months
#Friedreich#ataxia#MRI@ihharding@Mon_Bio_Imagingpic.twitter.com/kTuuO6HE7F
-
#366DiasdeEERR Ensayo fase 1#CTI_1601 Terapia potencial para la#Ataxia#Friedreich#AF Aprobada@US_FDA para@Zafgen y#ChondrialTx fusionadas en Larimar Therapeutics avanzando en esta terapia de reemplazo de proteínas q apoya@CureFA_org Gr.@FEDAES https://fedaes.org/ensayo-de-fase-1-de-cti-1601-prueba-de-terapia-potencial-para-la-ataxia-de-friedreich/ …pic.twitter.com/Gzl4CppyEV
-
Maintaining safe & effective swallowing function in
#Friedreich#ataxia is incredibly important from@MeganKeage@UniMelbMDHS@MCRI_for_kids https://www.sciencedirect.com/science/article/abs/pii/S0960896619311046 …pic.twitter.com/uHleGN6FEa
-
Excited to present my first doctoral thesis study, which has just been published! We investigated what different white matter
#MRI modalities can tell us about the disease process in#Friedreich#ataxia
https://onlinelibrary.wiley.com/doi/full/10.1002/hbm.24921 …Prikaži ovu nit -
L’Associació Francesa de l’atàxia de
#Friedreich concedeix una ajuda de 25.000 € a@IRBLleida_Info per validar el potencial terapèutic del calcitriol@Friedreichsatax@ACAH_ataxiaCat http://www.irblleida.org/ca/noticies/983/l-associacio-francesa-de-l-ataxia-de-friedreich-concedeix-una-ajuda-de-25-000-per-validar-el-potencial-terapeutic-del-calcitriol-per-tractar-aquesta-malaltia-rara …pic.twitter.com/MbUt9GGZKN
-
Looking forward to sharing my longitudinal analysis of brain white matter in
#Friedreich#ataxia - find me at Poster #35 (Natural History, Biomarkers and Endpoints)#IARC2019
pic.twitter.com/FwolrtcqAc
-
We are excited about these results of
#friedreich#ataxia#Clinicaltrial using omaveloxone@ReataPharma The positive effect of omaveloxone in#Friedreich#ataxia was first shown in our lab by Dr Rosella Abeti and published here https://www.ncbi.nlm.nih.gov/pubmed/30065630#preclinical#research https://twitter.com/ReataPharma/status/1183860453170171905 …pic.twitter.com/FhTpa2MkhS
-
Today is International Ataxia Awareness Day. Ataxia is a rare neurological disease impacting daily activities such as walking and talking. Through my
#MRI research, I hope to contribute to better outcomes for individuals with#Friedreich#ataxia.#IAAD19#UnitedAgainstAtaxiapic.twitter.com/J7Pedc2qSD
-
#Friedreich#ataxia is also a good candidate for#genetherapy with more studies to do on the best way to deliver the#treatment to#patients by systemic injection or combined injection - ongoing progress reported by Massimo Pandolfo at the annual meeting@ERN_RND@AtaxiaUKpic.twitter.com/GkBLO02MMY
-
My supervisor
@ihharding will be presenting my multi-modal longitudinal analysis of white matter in#Friedreich#ataxia at today's#OHBM2019 poster session (W220). This work is part of the IMAGE-FRDA Study, based at@turnerinstitute and@MCRI_for_kids.@gary_egan@RShishegarpic.twitter.com/iQWzsbCTX3
-
J’interroge le @MinSoliSante sur le#PlanMaladiesRares 2018-2022 et la prise en compte de l’ataraxie de#Friedreich et la maladie de#Tarlov.
https://www.lauriannerossi.fr/a-lassemblee-nationale/qe-maladies-rares/ … -
Kyle Bryant is a rare disease advocate and the founder/director of
@rideATAXIA for the#Friedreich’s Ataxia Research Alliance#FARA. Kyle and his team produce family friendly bike rides to empower those with Friedreich’s Ataxia @ataxiaandme@KyleABryanthttps://checkrare.com/kyle-bryant-discusses-the-rare-disease-community-and-his-journey-with-friedreichs-ataxia/ … -
In the
#RareDiseaseDay
Our member Minoryx Therapeutics receives approval from @AEMPSGOB to initiate phase 2 study in#Friedreich's Ataxia http://ow.ly/PooH30nRXkd#researchpic.twitter.com/77rjNWVebw
-
Our lab is working hard on
#RareDiseaseDay and every day on#drugdiscovery for#Friedreich's#Ataxia@CureFA_org@AtaxiaUK In this video@Gabriel_Barn is looking for#Frataxin changes@gvilemaenriquez https://www.dpag.ox.ac.uk/team/gabriele-corda …pic.twitter.com/JDITvQndUh -
#Minoryx recibe la aprobación de la Agencia Reguladora Española para iniciar el estudio de fase 2 en la ataxia de#Friedreich, que en España afecta a unas 2.000 personas
http://www.minoryx.com/ pic.twitter.com/iSKdTIOuyT
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.